UK health service under fire over access to hepatitis C drugs

LONDON, July 28 (Reuters) - British health authorities

improperly restrict access to expensive new hepatitis C drugs

that can cure the liver-destroying disease, patient groups and a

leading medical journal charged on Thursday.

Read more